Join us at the Influenza Vaccines for the World Conference in Lausanne, Switzerland, April 19-21, 2017. Dr. Kathy Rowlen will be speaking about the VaxArray platform and I&L Biosystems will be representing InDevR with a table top booth. Please contact us if you wish to schedule a time to meet.
InDevR CEO, Dr. Kathy Rowlen, gave a presentation at HHS regarding InDevR’s success at translating fundamental research into high-impact commercial products that are focused on improved analysis and characterization of vaccines.
InDevR participated in the recent ISIRV Options IX Conference. In addition to the exhibiting, InDevR scientists presented a number of posters on the FluChip-8G, VaxArray Influenza and Cypher One products.